Caffeinated Chewing Gum on 400-meter Performance
Launched by CHIH-HUI CHIU · May 24, 2024
Trial Information
Current as of February 19, 2025
Completed
Keywords
ClinConnect Summary
The purpose of this study was to investigate the effect of caffeinated chewing gum on 400-meter sprint performance. 20 trained sprinter were divided into caffeine Gum trial (CAF) and Placebo trial (PL) with a randomized, double-blind study design. The participants chewing either caffeine Gum (CAF trial, containing 3 mg/kg of caffeine) or Placebo Gum (PL) for 10 minutes. After rested for 15 minutes, the participants underwent a Running-Based Anaerobic Sprint Test. After a 30-minute break, a 400-meter sprint test was performed. The blood lactate concentration were collected before and after 4...
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • 6 years of professional short sprinting training
- • 6 months of ongoing training, and
- • 3 months of recovery from sports injuries such as strains and sprains.
- Exclusion Criteria:
- • Non-specialized sprinters.
- • has not trained regularly for the past 6 months.
- • has recovered from an athletic injury.
- • less than 3 months of recovery from a sports injury, or participants with epilepsy, hypertension, hyperlipidemia, heart disease, arthritis, osteoporosis, brain injury, or a history of caffeine allergy.
Trial Officials
ChihHui Chiu, PhD
Principal Investigator
Sport Science Research Center
About Chih Hui Chiu
Chih-Hui Chiu is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative clinical studies. With a strong background in clinical development and a focus on therapeutic areas that address unmet medical needs, Chiu leads a team of experienced professionals who prioritize ethical practices and rigorous scientific methodologies. By fostering collaborations with healthcare institutions and regulatory bodies, Chih-Hui Chiu aims to facilitate the efficient translation of research findings into effective treatments, ultimately enhancing the quality of care for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taichung, , Taiwan
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0